Clinical Medicine III. Posters
Dr. Balogh, Anikó
Department of Ophthalmology, Semmelweis University, Budapest, Hungary
aniko90127@gmail.com
Position of Macula Lutea and Presence of Proliferative Vitreoretinopathy Affect Intravitreal Cytokine Expression in Rhegmatogenous Retinal Detachment
Anikó Balogh1,2, Tibor Milibák2, Viktória Szabó1, Zoltán Zsolt Nagy1, Miklós D Resch1
1 Department of Ophthalmology, Semmelweis University, Budapest, Hungary
2 Department of Ophthalmology, Uzsoki Hospital Budapest, Hungary
Clinical Medicine III. Posters
Hungarian
Clinical Medicine
Molecular Sciences
Introduction: Our purpose was to evaluate the concentrations of intravitreal cytokines in patients with rhegmatogenous retinal detachment (RRD). We hypothesized that patients with macula on RRD have lower levels of cytokines compared to patients with macula off RRD and proliferative vitreoretinopathy (PVR).
Methods: Vitreous fluids were collected during 23G pars plana vitrectomy from 58 eyes of 58 patients. Indication for vitrectomy included macula off and macula on RRD, PVR, and idiopathic epiretinal membrane (ERM). A multiplex chemiluminescent immunoassay was performed to measure the concentrations of 48 cytokines, chemokines, and growth factors.
Results: Levels of HGF, IL-6, IL-8, IL-16, IFN-gamma, MCP-1, and MIF were significantly higher in all groups of retinal detachment compared to ERM. Levels of CTACK, eotaxin, G-CSF, IP-10, MIG, SCF, SCGF-beta, SDF-1alpha were significantly higher in PVR compared to macula on RRD and ERM. Levels of IL-1ra, IL-5, IL-9, M-CSF, MIP-1alpha, and TRIAL were significantly higher in PVR compared to macula on RRD.
Conclusions: Our results indicate that the position of macula lutea and the presence of PVR significantly influence the intravitreal cytokine expression. The detected proteins may serve as biomarkers to estimate the possibility of PVR formation and may help to invent personalized therapeutic strategies to slow down or prevent PVR.
Additional information:
„SUPPORTED BY THE ÚNKP-19-3-I NEW NATIONAL EXCELLENCE PROGRAM OF THE MINISTRY FOR INNOVATION AND TECHNOLOGY.”
Poszter
Szabad
elfogadva
poszter
nem rendelkezett róla
5133
12:25
12:28
Anikó Balogh1,2, Tibor Milibák2, Viktória Szabó1, Zoltán Zsolt Nagy1, Miklós D Resch1
1 Department of Ophthalmology, Semmelweis University, Budapest, Hungary
2 Department of Ophthalmology, Uzsoki Hospital Budapest, Hungary